- Home
- LAB vs AXGN Comparison
LAB vs AXGN Comparison
Compare LAB & AXGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LAB
- AXGN
- Stock Information
- Founded
- LAB 1999
- AXGN N/A
- Country
- LAB United States
- AXGN United States
- Employees
- LAB N/A
- AXGN N/A
- Industry
- LAB Biotechnology: Laboratory Analytical Instruments
- AXGN Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- LAB Industrials
- AXGN Health Care
- Exchange
- LAB Nasdaq
- AXGN Nasdaq
- Market Cap
- LAB 462.4M
- AXGN 517.4M
- IPO Year
- LAB 2011
- AXGN N/A
- Fundamental
- Price
- LAB $1.24
- AXGN $11.42
- Analyst Decision
- LAB Buy
- AXGN Strong Buy
- Analyst Count
- LAB 2
- AXGN 5
- Target Price
- LAB $2.50
- AXGN $26.00
- AVG Volume (30 Days)
- LAB 2.8M
- AXGN 786.9K
- Earning Date
- LAB 07-30-2025
- AXGN 08-07-2025
- Dividend Yield
- LAB N/A
- AXGN N/A
- EPS Growth
- LAB N/A
- AXGN N/A
- EPS
- LAB N/A
- AXGN N/A
- Revenue
- LAB $169,687,000.00
- AXGN $194,520,000.00
- Revenue This Year
- LAB N/A
- AXGN $18.08
- Revenue Next Year
- LAB $12.18
- AXGN $16.15
- P/E Ratio
- LAB N/A
- AXGN N/A
- Revenue Growth
- LAB 33.86
- AXGN 18.81
- 52 Week Low
- LAB $0.92
- AXGN $7.34
- 52 Week High
- LAB $2.41
- AXGN $21.00
- Technical
- Relative Strength Index (RSI)
- LAB 52.66
- AXGN 63.05
- Support Level
- LAB $1.27
- AXGN $11.61
- Resistance Level
- LAB $1.41
- AXGN $12.28
- Average True Range (ATR)
- LAB 0.08
- AXGN 0.51
- MACD
- LAB -0.00
- AXGN 0.25
- Stochastic Oscillator
- LAB 38.46
- AXGN 87.58
About LAB Standard BioTools Inc.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.
About AXGN Axogen Inc.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.